ISPOR - EE564 Cost-Effectiveness of Alirocumab in Combination With High-Intensity Statin and Ezetimibe in Adults With Atherosclerotic Cardiovascular Disease (ASCVD) in Taiwan

Full Text

EE564 Cost-Effectiveness of Alirocumab in Combination With High-Intensity Statin and Ezetimibe in Adults With Atherosclerotic Cardiovascular Disease (ASCVD) in Taiwan

Abstract

Authors

ECH Tan CL Yang

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now